Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04469712

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Long-term Outcomes of Bariatric Patients Treated With Gastric Bypass or Single-anastomosis Sleeve Ileal Bypass (SASI Bipartition)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
280 (estimated)
Sponsor
Aleris Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The main aim of this project is to assess the safety and efficiency of the SASI Bipartition.

Detailed description

The Roux-en-Y Gastric Bypass (RYGB) is the procedure of choice in morbid obesity with metabolic disorders in most of the reference centers. Recent data describes the SASI Bipartition as being as efficient on weight loss and co-morbidities as the RYGB, with the advantage of being less technically difficult and less morbidity. In order to draw definite conclusions regarding the procedure, larger series with longer follow-up are necessary. Patients with BMI over 40, or with BMI over 35 with comorbidities are offered SASI Bipartition with 300 cm common limb or standard RYGB. Follow up is performed through visits at 3, 12, 24, 36, 48, and 60 months after surgery. Results on weight loss, comorbidities resolution, complications, and need of supplements are registered.

Conditions

Interventions

TypeNameDescription
PROCEDURESASI BipartitionSASI Bipartition is performed with a sleeve gastrectomy over a 32 French gastric bougie and a 300 cm common limb. Side-to-side gastroileostomy with a diameter of approximately 2.5 cm at the anterior part of antrum, 6 cm proximal to pylorus.
PROCEDUREGastric bypassA small gastric pouch (15 mL) is created, and the jejunum brought up as an antecolic and antegastric fashion. Routine limb lengths were 150 cm for the alimentary limb and 60 cm for the bilio-pancreatic limb. Both mesenteric defects are closed with the Endohernia® stapler.

Timeline

Start date
2020-08-01
Primary completion
2027-07-01
Completion
2027-08-01
First posted
2020-07-14
Last updated
2025-02-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04469712. Inclusion in this directory is not an endorsement.